Biosplice Therapeutics
Pre-clinicalIn human DNA, approximately 20,000 genes code for hundreds of thousands of distinct proteins required for normal tissue development and function. This is possible because a single gene can translate into multiple protein variants, with distinct and sometimes opposing function, through a dynamic and heavily regulated mechanism known as alternative pre-mRNA splicing, commonly known as alternative splicing.
About
In human DNA, approximately 20,000 genes code for hundreds of thousands of distinct proteins required for normal tissue development and function. This is possible because a single gene can translate into multiple protein variants, with distinct and sometimes opposing function, through a dynamic and heavily regulated mechanism known as alternative pre-mRNA splicing, commonly known as alternative splicing.
Funding History
3Total raised: $400M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile